Targeted next generation sequencing reveals a novel intragenic deletion of the TPO gene in a family with intellectual disability.

Autor: Iqbal Z; Department of Human Genetics, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, The Netherlands., Neveling K, Razzaq A, Shahzad M, Zahoor MY, Qasim M, Gilissen C, Wieskamp N, Kwint MP, Gijsen S, de Brouwer AP, Veltman JA, Riazuddin S, van Bokhoven H
Jazyk: angličtina
Zdroj: Archives of medical research [Arch Med Res] 2012 May; Vol. 43 (4), pp. 312-6. Date of Electronic Publication: 2012 Mar 03.
DOI: 10.1016/j.arcmed.2012.01.011
Abstrakt: Backgrounds and Aims: Next generation sequencing (NGS) approaches have revolutionized the identification of mutations underlying genetic disorders. This technology is particularly useful for the identification of mutations in known and new genes for conditions with extensive genetic heterogeneity. In the present study we investigated a consanguineous Pakistani family with intellectual disability (ID).
Methods: Genotyping was carried out using 250k and 6k SNP microarrays in order to perform homozygosity mapping and copy number variation (CNV) analysis. Targeted NGS was performed to identify the genetic defect in this family. qPCR was performed to validate and confirm the NGS result.
Results: Homozygosity mapping positioned the causative defect on chromosome 2p25.3-p25.2. Subsequent targeted NGS revealed an intragenic deletion of five exons of the gene TPO.
Conclusions: NGS is a powerful method to uncover submicroscopic structural variations. This result demonstrates that an unbiased screening approach such as NGS can help to identify even unexpected disease-causing mutations.
(Copyright © 2012 IMSS. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: